- Home
- BIDU vs INM Comparison
BIDU vs INM Comparison
Compare BIDU & INM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BIDU
- INM
- Stock Information
- Founded
- BIDU 2000
- INM 1981
- Country
- BIDU China
- INM Canada
- Employees
- BIDU N/A
- INM N/A
- Industry
- BIDU Computer Software: Programming Data Processing
- INM Biotechnology: Pharmaceutical Preparations
- Sector
- BIDU Technology
- INM Health Care
- Exchange
- BIDU Nasdaq
- INM Nasdaq
- Market Cap
- BIDU 30.9B
- INM 4.3M
- IPO Year
- BIDU 2005
- INM N/A
- Fundamental
- Price
- BIDU $115.47
- INM $2.18
- Analyst Decision
- BIDU Buy
- INM
- Analyst Count
- BIDU 8
- INM 0
- Target Price
- BIDU $105.75
- INM N/A
- AVG Volume (30 Days)
- BIDU 6.1M
- INM 40.0K
- Earning Date
- BIDU 08-20-2025
- INM 11-13-2025
- Dividend Yield
- BIDU N/A
- INM N/A
- EPS Growth
- BIDU 41.81
- INM N/A
- EPS
- BIDU 10.88
- INM N/A
- Revenue
- BIDU $18,544,068,789.00
- INM $4,920,990.00
- Revenue This Year
- BIDU $0.76
- INM N/A
- Revenue Next Year
- BIDU $5.02
- INM N/A
- P/E Ratio
- BIDU $10.55
- INM N/A
- Revenue Growth
- BIDU N/A
- INM N/A
- 52 Week Low
- BIDU $74.71
- INM $1.72
- 52 Week High
- BIDU $116.91
- INM $8.27
- Technical
- Relative Strength Index (RSI)
- BIDU 81.70
- INM 44.27
- Support Level
- BIDU $106.81
- INM $2.11
- Resistance Level
- BIDU $116.91
- INM $2.28
- Average True Range (ATR)
- BIDU 2.75
- INM 0.10
- MACD
- BIDU 2.06
- INM 0.02
- Stochastic Oscillator
- BIDU 95.08
- INM 55.59
About BIDU Baidu Inc. ADS
Baidu is the largest internet search engine in China with over 50% share of the search engine market in 2024 per web analytics firm, Statcounter. The firm generated 72% of core revenue from online marketing services from its search engine in 2023. Outside its search engine, Baidu is a technology-driven company and its other major growth initiatives are artificial intelligence cloud, video streaming services, voice recognition technology, and autonomous driving.
About INM InMed Pharmaceuticals Inc.
InMed Pharmaceuticals Inc is a Canada based clinical-stage biopharmaceutical company. The company is engaged in the research and development of novel, cannabinoid-based, and manufacturing of Pharmaceutical grade cannabinoids. Its product portfolio includes INM-755, which is used for the treatment of epidermolysis bullosa; INM-088 for the treatment of glaucoma; INM-901 for Alzheimer's disease, INM-089's pharmacological and IntegraSyn which is a manufacturing system for Pharmaceutical-Grade Cannabinoids.